Zenith Healthcare Limited (BOM:530665)
India · Delayed Price · Currency is INR 3.080
-0.010 (-0.32%)
At close: Aug 17, 2026
Zenith Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 108.04 | 105.22 | 113.3 | 144.72 | 131.29 | 223.62 |
Other Revenue | -0.55 | 0.42 | 0.6 | 0.88 | 0.95 | 1.96 |
| 107.48 | 105.64 | 113.89 | 145.61 | 132.25 | 225.58 | |
Revenue Growth | -9.75% | -7.25% | -21.78% | 10.10% | -41.38% | 62.78% |
Cost of Revenue | 50.23 | 50.4 | 55.66 | 85.01 | 81.85 | 127.09 |
Gross Profit | 57.26 | 55.24 | 58.23 | 60.59 | 50.4 | 98.49 |
Selling, General & Admin | 21.64 | 20.81 | 18.61 | 18.68 | 16.97 | 17.7 |
Other Operating Expenses | 34.44 | 35.31 | 38.26 | 38.65 | 32.05 | 73.93 |
Operating Expenses | 58.67 | 58.7 | 59.2 | 59.42 | 51.82 | 95.21 |
Operating Income | -1.41 | -3.46 | -0.97 | 1.17 | -1.43 | 3.28 |
Interest Expense | - | - | - | - | -0 | - |
Interest & Investment Income | 2.5 | 2.47 | 2.08 | 0.74 | 0.51 | 0.45 |
Currency Exchange Gain (Loss) | 0.67 | 0.67 | 0.18 | 0.18 | 1.98 | 1.59 |
Other Non Operating Income (Expenses) | 0.36 | 0.36 | 0.89 | 0.67 | 0.12 | 0.78 |
EBT Excluding Unusual Items | 2.11 | 0.04 | 2.18 | 2.76 | 1.18 | 6.1 |
Gain (Loss) on Sale of Investments | 0.12 | 0.12 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.61 | - | - | - |
Other Unusual Items | - | - | - | - | - | -0.04 |
Pretax Income | 2.23 | 0.16 | 2.79 | 2.76 | 1.18 | 6.06 |
Income Tax Expense | 0.63 | 0.11 | 2.12 | 0.72 | 0.4 | 2.95 |
Net Income | 1.6 | 0.05 | 0.67 | 2.04 | 0.78 | 3.11 |
Net Income to Common | 1.6 | 0.05 | 0.67 | 2.04 | 0.78 | 3.11 |
Net Income Growth | - | -92.39% | -67.08% | 161.57% | -74.95% | -29.40% |
Shares Outstanding (Basic) | 52 | 54 | 54 | 54 | 54 | 54 |
Shares Outstanding (Diluted) | 52 | 54 | 54 | 54 | 54 | 54 |
Shares Change | -3.82% | - | - | - | - | - |
EPS (Basic) | 0.03 | 0.00 | 0.01 | 0.04 | 0.01 | 0.06 |
EPS (Diluted) | 0.03 | 0.00 | 0.01 | 0.04 | 0.01 | 0.06 |
EPS Growth | - | -92.39% | -67.08% | 170.49% | -75.78% | -29.40% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -9.93 | 1.69 | 16.3 | -9.55 | 10.79 |
Free Cash Flow Per Share | - | -0.18 | 0.03 | 0.30 | -0.18 | 0.20 |
Gross Margin | 53.27% | 52.29% | 51.13% | 41.61% | 38.11% | 43.66% |
Operating Margin | -1.31% | -3.28% | -0.85% | 0.80% | -1.08% | 1.45% |
Profit Margin | 1.49% | 0.05% | 0.59% | 1.40% | 0.59% | 1.38% |
Free Cash Flow Margin | - | -9.40% | 1.48% | 11.20% | -7.22% | 4.78% |
EBITDA | 1.24 | -0.88 | 1.36 | 3.26 | 1.38 | 6.86 |
EBITDA Margin | 1.15% | -0.83% | 1.19% | 2.24% | 1.04% | 3.04% |
D&A For EBITDA | 2.65 | 2.58 | 2.32 | 2.09 | 2.8 | 3.58 |
EBIT | -1.41 | -3.46 | -0.97 | 1.17 | -1.43 | 3.28 |
EBIT Margin | -1.31% | -3.28% | -0.85% | 0.80% | -1.08% | 1.45% |
Effective Tax Rate | 28.30% | 67.92% | 76.00% | 26.21% | 34.12% | 48.75% |
Revenue as Reported | 111.21 | 109.37 | 117.61 | 147.35 | 135.05 | 228.84 |
Advertising Expenses | - | 2.79 | 1.21 | 3.54 | 0.31 | 0.15 |